Canada's Population Health Model (POHEM): a tool for performing economic evaluations of cancer control interventions

This publication has 10 references indexed in Scilit:

• Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer.
  JNCI Journal of the National Cancer Institute, 2000
• Estimates of the lifetime costs of breast cancer treatment in Canada
  European Journal Of Cancer, 2000
• Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer
  JNCI Journal of the National Cancer Institute, 1999
• Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancer
  British Journal of Cancer, 1999
• Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs
  British Journal of Cancer, 1999
• Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
  JNCI Journal of the National Cancer Institute, 1998
• Cost of combined modality interventions for stage III non-small-cell lung cancer.
  Journal of Clinical Oncology, 1997
• The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer
  European Journal Of Cancer, 1996
• Diagnostic and therapeutic approaches to lung cancer in Canada and their costs
  British Journal of Cancer, 1995
• Management of Metastatic Non-Small-Cell Lung Cancer and a Consideration of Cost
  Chest, 1993